financetom
Business
financetom
/
Business
/
Top Premarket Gainers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Premarket Gainers
May 7, 2024 4:59 AM

07:36 AM EDT, 05/07/2024 (MT Newswires) -- Esperion Therapeutics ( ESPR ) shares surged more than 25% Tuesday premarket after the company posted improved Q1 financial results.

FibroGen ( FGEN ) shares rose nearly 20% after the company reported a narrower Q1 loss on higher revenue.

Zeta Global Holdings ( ZETA ) shares increased 15% after posting improved Q1 results and lifted its revenue guidance.

Price: 2.6700, Change: +0.55, Percent Change: +25.94

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Core Natural Resources Q4 Earnings, Revenue Decline
Core Natural Resources Q4 Earnings, Revenue Decline
Feb 20, 2025
07:09 AM EST, 02/20/2025 (MT Newswires) -- Core Natural Resources ( CNR ) reported Q4 earnings Thursday of $1.04 per diluted share, down from $5.05 a year earlier. Two analysts polled by FactSet expected $2.68. Revenue and other income for the quarter ended Dec. 31 was $595.3 million, compared with $649.4 million a year earlier. Two analysts surveyed by FactSet...
Freshpet Q4 Earnings, Net Sales Rise; 2025 Outlook Set
Freshpet Q4 Earnings, Net Sales Rise; 2025 Outlook Set
Feb 20, 2025
07:03 AM EST, 02/20/2025 (MT Newswires) -- Freshpet ( FRPT ) reported Q4 earnings Thursday of $0.36 per diluted share, up from $0.31 per share a year earlier. Analysts polled by FactSet expected $0.36 per share. Net sales for the quarter ended Dec. 31 were $262.7 million, compared with $215.4 million a year earlier. Analysts surveyed by FactSet expected $264.1...
AstraZeneca to buy FibroGen's China unit for $160 million
AstraZeneca to buy FibroGen's China unit for $160 million
Feb 20, 2025
Feb 20 (Reuters) - AstraZeneca ( AZN ) will buy U.S. biotech firm FibroGen's ( FGEN ) China unit for about $160 million, in its latest deal to boost its presence in the country despite growing US-China trade tensions. Fibrogen ( FGEN ) said the deal will give AstraZeneca ( AZN ) full rights to its anemia drug roxadustat in...
Springworks Therapeutics Q4 Net Loss Narrows
Springworks Therapeutics Q4 Net Loss Narrows
Feb 20, 2025
07:00 AM EST, 02/20/2025 (MT Newswires) -- Springworks Therapeutics ( SWTX ) reported a Q4 net loss Thursday of $1.04 per share, narrowing from a net loss of $1.44 a year earlier. Analysts polled by FactSet expected a loss of $0.71. Net product revenue for the quarter ended Dec. 31 was $61.5 million. The previous year's numbers were not provided....
Copyright 2023-2026 - www.financetom.com All Rights Reserved